RS49795B - Sredstva sa antidepresivnim dejstvom - Google Patents

Sredstva sa antidepresivnim dejstvom

Info

Publication number
RS49795B
RS49795B YUP-4/01A YU40199A RS49795B RS 49795 B RS49795 B RS 49795B YU 40199 A YU40199 A YU 40199A RS 49795 B RS49795 B RS 49795B
Authority
RS
Serbia
Prior art keywords
agents
antidepressive effect
arnino
antidepressive
effect
Prior art date
Application number
YUP-4/01A
Other languages
English (en)
Inventor
Jerzy MAJ
Original Assignee
Boehringer Ingelheim Pharma Gmbh.&Co.Kg.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh.&Co.Kg., filed Critical Boehringer Ingelheim Pharma Gmbh.&Co.Kg.,
Priority claimed from PCT/EP1999/004599 external-priority patent/WO2000002755A1/de
Publication of RS49795B publication Critical patent/RS49795B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sredstvo za lečenje depresije koje sadrži 2-arnino-4,5,6,7-te1rahidro-6-propil-arnino-benzotiazol, jedan od njegovih enantiomera ili jednu od njegovih adicionih soli sa kiselinom, u kombinaciji sa sertralinom ili sa jednom od njegovih farmakološki prihvatljivih soli. Prijava sadrži još 13 zahteva.
YUP-4/01A 1998-07-07 1999-07-02 Sredstva sa antidepresivnim dejstvom RS49795B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004599 WO2000002755A1 (de) 1998-07-08 1999-07-02 Bremsdrucksteuergerät

Publications (1)

Publication Number Publication Date
RS49795B true RS49795B (sr) 2008-06-05

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-4/01A RS49795B (sr) 1998-07-07 1999-07-02 Sredstva sa antidepresivnim dejstvom

Country Status (33)

Country Link
US (1) US6255329B1 (sr)
EP (1) EP1093369B1 (sr)
JP (1) JP2002520273A (sr)
KR (1) KR100557692B1 (sr)
CN (1) CN1230168C (sr)
AR (1) AR019896A1 (sr)
AT (1) ATE228365T1 (sr)
AU (1) AU762128B2 (sr)
BG (1) BG64972B1 (sr)
BR (1) BR9911768A (sr)
CA (1) CA2336833C (sr)
CZ (1) CZ294087B6 (sr)
DE (2) DE19830201A1 (sr)
DK (1) DK1093369T3 (sr)
EA (1) EA003142B1 (sr)
EE (1) EE04296B1 (sr)
ES (1) ES2183583T3 (sr)
HK (1) HK1037976A1 (sr)
HU (1) HUP0103922A3 (sr)
ID (1) ID27776A (sr)
IL (1) IL140603A0 (sr)
MY (1) MY117969A (sr)
NO (1) NO20010064L (sr)
NZ (1) NZ509729A (sr)
PL (1) PL195043B1 (sr)
PT (1) PT1093369E (sr)
RS (1) RS49795B (sr)
SK (1) SK284923B6 (sr)
TR (1) TR200100146T2 (sr)
TW (1) TW592698B (sr)
WO (1) WO2000002542A2 (sr)
YU (1) YU401A (sr)
ZA (1) ZA200100090B (sr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
KR20040066890A (ko) * 2001-12-11 2004-07-27 유니버시티 오브 버지니아 페이턴트 파운데이션 근위축성 측삭 경화증 치료를 위한 프라미펙솔의 용도
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
EP1708706A1 (en) * 2004-01-22 2006-10-11 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
JP2009504748A (ja) * 2005-08-15 2009-02-05 ユニバーシティ オブ バージニア パテント ファウンデーション Ｒ（＋）プラミペキソールを用いた神経回復
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
ATE537826T1 (de) 2006-05-16 2012-01-15 Knopp Neurosciences Inc Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
EP2137171A4 (en) 2007-03-14 2010-05-19 Knopp Neurosciences Inc SYNTHESIS OF BENZOTHIAZOLE DIAMINES SUBSTITUTED AND PURIFIED FROM THE CHIRAL PERSPECTIVE
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
ES2459322T3 (es) 2008-09-05 2014-05-09 Supernus Pharmaceuticals, Inc. Método de tratamiento de trastorno de déficit de atención con hiperactividad (TDAH)
AU2010242971A1 (en) * 2009-04-30 2011-11-24 Supernus Pharmaceuticals, Inc. Method of treatment of depression
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
RS61539B1 (sr) 2013-07-12 2021-04-29 Knopp Biosciences Llc Lečenje povišenih nivoa eozinofila i/ili bazofila
CA2921381A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
MA51658A (fr) * 2017-04-10 2020-12-02 Chase Therapeutics Corp Association comprenant un antagoniste de nk1 et méthode de traitement de synucléinopathies
EP3645120A4 (en) * 2017-06-30 2021-03-24 Chase Pharmaceuticals Corporation NK-1 ANTAGONIST COMPOSITIONS AND METHODS OF USE IN THE TREATMENT OF DEPRESSION
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
TR199801929T2 (xx) * 1996-03-29 1998-12-21 Pfizer Inc. Benzil(iden)-laktam t�revleri, bunlar�n 5-HT1A resept�rlerinin (ant)agonistler olarak kullan�mlar� .
ATE282417T1 (de) * 1996-12-02 2004-12-15 Merck Sharp & Dohme Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen
CN1293573A (zh) * 1998-01-13 2001-05-02 同步神经元有限责任公司 迟发性运动障碍和其它运动疾病的治疗方法

Also Published As

Publication number Publication date
IL140603A0 (en) 2002-02-10
EA003142B1 (ru) 2003-02-27
AR019896A1 (es) 2002-03-20
CZ200177A3 (en) 2001-06-13
KR100557692B1 (ko) 2006-03-07
CN1230168C (zh) 2005-12-07
US6255329B1 (en) 2001-07-03
TR200100146T2 (tr) 2001-07-23
HUP0103922A3 (en) 2002-08-28
BR9911768A (pt) 2001-04-03
NZ509729A (en) 2003-06-30
ID27776A (id) 2001-04-26
CA2336833A1 (en) 2000-01-20
PL345842A1 (en) 2002-01-14
CA2336833C (en) 2008-09-23
AU762128B2 (en) 2003-06-19
NO20010064D0 (no) 2001-01-05
AU5030399A (en) 2000-02-01
HK1037976A1 (en) 2002-03-01
SK284923B6 (sk) 2006-02-02
BG105112A (en) 2001-10-31
EP1093369B1 (de) 2002-11-27
DE19830201A1 (de) 2000-01-13
PT1093369E (pt) 2003-03-31
JP2002520273A (ja) 2002-07-09
TW592698B (en) 2004-06-21
WO2000002542A3 (de) 2000-06-22
HUP0103922A2 (hu) 2002-03-28
SK112001A3 (en) 2001-10-08
ZA200100090B (en) 2002-04-04
EE200100014A (et) 2002-06-17
DK1093369T3 (da) 2002-12-16
WO2000002542A2 (de) 2000-01-20
EE04296B1 (et) 2004-06-15
ES2183583T3 (es) 2003-03-16
BG64972B1 (bg) 2006-11-30
KR20010079491A (ko) 2001-08-22
MY117969A (en) 2004-08-30
DE59903556D1 (de) 2003-01-09
EA200100084A1 (ru) 2001-08-27
ATE228365T1 (de) 2002-12-15
CZ294087B6 (cs) 2004-10-13
CN1308533A (zh) 2001-08-15
PL195043B1 (pl) 2007-08-31
EP1093369A2 (de) 2001-04-25
NO20010064L (no) 2001-03-02
YU401A (sh) 2003-10-31

Similar Documents

Publication Publication Date Title
RS49795B (sr) Sredstva sa antidepresivnim dejstvom
NO983189L (no) Nye substituerte imidazolforbindelser
PT935465E (pt) Compostos novos de imidazole substituido
ATE302770T1 (de) Benzimidazolverbindungen die nociceptinrezeptoraffinität haben
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
EE9700310A (et) N-propargüül-1-aminoindaani R-enantiomeeri, selle soolade ja kompositsioonide kasutamine
NO970162L (no) Substituerte pyrimidinforbindelser og anvendelse derav
BR0014078A (pt) Inibidores de fator xa
AR023777A1 (es) Nuevos compuestos
DE59914814D1 (de) Heterozyklische substituierte amide, deren herstellung und anwendung
CY1112605T1 (el) Οπτικως ενεργα ισομερη κετοτιφαινης και θεραπευτικως δραστικοι μεταβολιτες αυτων
TR200000756T2 (tr) Davranış bozukluğu tedavisi.
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
PT998460E (pt) Novos derivados de tetrazole
NO976074L (no) To- og treverdige småmolekylinhibitorer for selektin
ES2150039T3 (es) Benzonitrilos como 5-ht agonistas y antagonistas.
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
BG106681A (en) Solutions containing epinastine
TR200201250T2 (tr) Hidroksieikosatetraenoat tuzları, bileşimleri ve bunların göz kuruması bozukluklarının iyileştirilmesinde kullanım yöntemleri.
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
AR022321A1 (es) Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada
SE9802209D0 (sv) Novel compounds
BR9914899A (pt) Uso de (r)-tofisopam opticamente puro para o tratamento e a prevenção de distúrbios de ansiedade e composição do mesmo
ATE320422T1 (de) Metalloproteinase inhibitoren